The primary structure of the human pancreatic secretory trypsin inhibitor
about
A low-molecular-mass Kazal-type protease inhibitor isolated from rat hepatocytes is identical to rat pancreatic secretory trypsin inhibitor II. Purification and amino acid sequenceNonenzymatic deamidation of asparaginyl and glutaminyl residues in proteins.A camel milk whey protein rich in half-cystine. Primary structure, assessment of variations, internal repeat patterns, and relationships with neurophysin and other active polypeptides.Amino acid sequence elucidation of human acrosin-trypsin inhibitor (HUSI-II) reveals that Kazal-type proteinase inhibitors are structurally related to beta-subunits of glycoprotein hormones.Therapeutic targeting of SPINK1-positive prostate cancer.Biochemistry and clinical role of trypsinogens and pancreatic secretory trypsin inhibitor.Serine protease inhibitor Kazal type 1 promotes epithelial-mesenchymal transition through EGFR signaling pathway in prostate cancer.Role of the inflammatory protein serine protease inhibitor Kazal in preventing cytolytic granule granzyme A-mediated apoptosis.Purification and immunochemical quantitation of human pancreatic secretory trypsin inhibitor.A novel discriminant score based on tumor-associated trypsin inhibitor for accurate diagnosis of metastasis in patients with breast cancer.Serine protease inhibitor Kazal type 1 and epidermal growth factor receptor are expressed in pancreatic tubular adenocarcinoma, intraductal papillary mucinous neoplasm, and pancreatic intraepithelial neoplasia.Pancreatitis risk in primary hyperparathyroidism: relation to mutations in the SPINK1 trypsin inhibitor (N34S) and the cystic fibrosis gene.
P2860
Q28299073-75A23A97-9576-48F0-B038-E5FFA3F68A32Q30355031-4B32C53D-8AC1-4BF4-90AF-3E19225227A0Q30406300-2A4DE5DF-4D24-40AB-9280-354A117A63F8Q34248960-2A02A8BC-FB7E-4D22-B3E1-779028C2036EQ35536144-3EFCAEC9-5990-4ECA-A54D-0A45EDF52FA0Q36414170-4E8E7FA4-FE21-4021-B221-62F2F6B7CC2EQ39016331-D2A17BF1-1EBF-4237-A95D-D12B55145760Q39449718-FBA3AE47-24D5-4B7F-885B-C78CA3D7FCDDQ39603357-F095D549-85DA-4F4D-820D-8D0CB5108F46Q42448688-D3BD05FC-411D-4669-A8F1-DA86355B45A9Q44432238-8ECA3560-D240-41FF-88C1-159A45965D02Q46852919-D4FC68B7-90E3-46C6-B951-D49CA8D82E16
P2860
The primary structure of the human pancreatic secretory trypsin inhibitor
description
im Februar 1977 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в лютому 1977
@uk
name
The primary structure of the human pancreatic secretory trypsin inhibitor
@en
The primary structure of the human pancreatic secretory trypsin inhibitor
@nl
type
label
The primary structure of the human pancreatic secretory trypsin inhibitor
@en
The primary structure of the human pancreatic secretory trypsin inhibitor
@nl
prefLabel
The primary structure of the human pancreatic secretory trypsin inhibitor
@en
The primary structure of the human pancreatic secretory trypsin inhibitor
@nl
P1476
The primary structure of the human pancreatic secretory trypsin inhibitor
@en
P2093
Diana C. Bartelt
Roslyn Shapanka
P304
P356
10.1016/0003-9861(77)90103-5
P407
P577
1977-02-01T00:00:00Z